Education
About Us
Working with TipRanks
Follow Us
BioSig Technologies Inc (BSGM)
NASDAQ:BSGM
Total Valuation
BioSig Technologies has a market cap or net worth of $161.19M. The enterprise value is $8.96M.
Market Cap$161.19M
Enterprise Value$8.96M
Share Statistics
BioSig Technologies has 35,270,943 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding35,270,943
Owned by Insiders13.33%
Owned by Institutions44.17%
Financial Efficiency
BioSig Technologies’s return on equity (ROE) is 7.18 and return on invested capital (ROIC) is 974.39%.
Return on Equity (ROE)7.18
Return on Assets (ROA)-12.27
Return on Invested Capital (ROIC)974.39%
Return on Capital Employed (ROCE)9.05
Revenue Per Employee8.00K
Profits Per Employee-2.07M
Employee Count5
Asset Turnover0.05
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of BioSig Technologies is ―. BioSig Technologies’s PEG ratio is ―.
PE Ratio―
PS Ratio―
PB Ratio―
Price to Fair Value-145.39
Price to FCF―
Price to Operating Cash Flow-300.22
PEG Ratio―
Income Statement
In the last 12 months, BioSig Technologies had revenue of 40.00K and earned -10.33M in profits. Earnings per share was -0.07.
Revenue40.00K
Gross Profit40.00K
Operating Income-12.86M
Pretax Income-10.34M
Net Income-10.33M
EBITDA-12.42M
Earnings Per Share (EPS)-0.07
Cash Flow
In the last 12 months, operating cash flow was -4.36M and capital expenditures 0.00, giving a free cash flow of -4.36M billion.
Operating Cash Flow-4.36M
Free Cash Flow-4.36M
Free Cash Flow per Share-0.12
Dividends & Yields
BioSig Technologies pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.02
52-Week Price Change880.00%
50-Day Moving Average5.50
200-Day Moving Average2.87
Relative Strength Index (RSI)42.95
Average Volume (3m)786.12K
Important Dates
BioSig Technologies upcoming earnings date is May 18, 2026, TBA (Confirmed).
Last Earnings DateMay 19, 2025
Next Earnings DateMay 18, 2026
Ex-Dividend Date―
Financial Position
BioSig Technologies as a current ratio of 0.15, with Debt / Equity ratio of -0.43%
Current Ratio0.15
Quick Ratio0.15
Debt to Market Cap0.00
Net Debt to EBITDA<0.01
Interest Coverage Ratio-1.17K
Taxes
In the past 12 months, BioSig Technologies has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
BioSig Technologies EV to EBITDA ratio is -16.84, with an EV/FCF ratio of -43.96.
EV to Sales5.23K
EV to EBITDA-16.84
EV to Free Cash Flow-43.96
EV to Operating Cash Flow-43.96
Balance Sheet
BioSig Technologies has $2.82M in cash and marketable securities with $15.00K in debt, giving a net cash position of -$2.81M billion.
Cash & Marketable Securities$2.82M
Total Debt$15.00K
Net Cash-$2.81M
Net Cash Per Share-$0.08
Tangible Book Value Per Share-$0.01
Margins
Gross margin is -300.00%, with operating margin of -32155.00%, and net profit margin of -25825.00%.
Gross Margin-300.00%
Operating Margin-32155.00%
Pretax Margin-25847.50%
Net Profit Margin-25825.00%
EBITDA Margin-31052.50%
EBIT Margin-31522.50%
Analyst Forecast
The average price target for BioSig Technologies is $10.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$10.00
Price Target Upside126.76% Upside
Analyst ConsensusModerate Buy
Analyst Count0
Revenue Growth Forecast-67.50%
EPS Growth Forecast45.54%